Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
Apr 28, 2025, 4:00 PM EDT

Altamira Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Market Capitalization
01627305
Upgrade
Market Cap Growth
-18.65%-75.59%-78.93%-10.02%459.12%-65.68%
Upgrade
Enterprise Value
15111830-1
Upgrade
Last Close Price
0.103.4897.00726.001048.00648.00
Upgrade
PB Ratio
0.070.18-0.631.881.580.86
Upgrade
P/TBV Ratio
0.280.45--3.46-
Upgrade
Debt / Equity Ratio
0.070.02-0.760.040.03-
Upgrade
Quick Ratio
0.150.780.060.343.740.71
Upgrade
Current Ratio
0.431.380.140.843.831.04
Upgrade
Return on Equity (ROE)
-369.51%--790.08%-44.88%-71.91%-136.94%
Upgrade
Return on Assets (ROA)
-57.04%-52.83%-27.56%-16.70%-21.99%-47.50%
Upgrade
Return on Capital (ROIC)
-99.71%-161.65%-60.38%-21.60%-28.31%-81.59%
Upgrade
Earnings Yield
-579.91%-332.00%-505.93%-69.52%-30.99%-128.00%
Upgrade
FCF Yield
--987.73%-165.60%-55.73%-18.30%-163.22%
Upgrade
Buyback Yield / Dilution
-1503.64%-978.83%-37.51%-120.26%--
Upgrade
Updated Sep 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.